Warp I'd like to offer up my opinion. This whole PPS problem would be rectified with volume. With volume, the spread closes and there are no more buy 3 at the bid, and sell 2 at a lower ask. I think there a lot of accumulation going on, albeit, slowly using that very same method. It seems like the volume will remain dry for some time until AMBS is in the spotlight. Hopefully their first entry in accounts receivable puts them front and center.
Until then, it's just a stormy PPS. But really, who cares? It seems AMBS is building very strong fundamentals and a strong foundation will hold up a price spike if one occurs.
Also, I might be a lone wolf with this one, but I despise a BP partnership. I am greedy. I want 100% MANF revenue. (As long as they can make ends meet with eventual Lympro bux.)
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links